NOVAVAX INC Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Novavax Inc quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2024.
  • Novavax Inc Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 160M shares, a 34.9% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 160M +41.4M +34.9% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 160M +65.6M +69.5% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 140M +54.1M +62.7% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 140M +53.5M +62.1% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 119M +40.3M +51.3% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 94.3M +16.1M +20.7% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 86.3M +8.17M +10.5% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 86M +10.2M +13.4% Dec 31, 2022 10-K 2024-02-28
Q3 2022 78.5M +3.06M +4.06% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 78.2M +3.92M +5.28% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 78.1M +4.06M +5.48% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 75.8M +4.89M +6.89% Dec 31, 2021 10-K 2023-02-28
Q3 2021 75.4M +12.5M +19.8% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 74.2M +13M +21.3% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 74.1M +20.2M +37.5% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 71M +38.6M +119% Dec 31, 2020 10-K 2022-03-01
Q3 2020 62.9M +37.4M +146% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 61.2M +37.7M +161% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 53.9M -416M -88.5% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 32.4M +13.1M +68.3% Dec 31, 2019 10-K 2021-03-01
Q3 2019 25.5M -357M -93.3% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 23.5M -358M -93.9% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 469M +123M +35.4% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 19.2M -304M -94.1% Dec 31, 2018 10-K 2020-03-11
Q3 2018 383M +72.5M +23.4% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 382M +91.8M +31.7% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 347M +64.1M +22.7% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 323M +52M +19.2% Dec 31, 2017 10-K 2019-03-18
Q3 2017 310M +38.9M +14.4% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 290M +19M +7.03% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 283M +11.8M +4.37% Mar 31, 2017 10-Q 2017-05-08
Q4 2016 271M +1.27M +0.47% Dec 31, 2016 10-K 2018-03-14
Q3 2016 271M +1.42M +0.53% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 271M +2.24M +0.83% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 271M +2.84M +1.06% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 270M +31.1M +13% Dec 31, 2015 10-K 2017-02-27
Q3 2015 270M +31.4M +13.2% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 269M +30.5M +12.8% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 268M +58.7M +28% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 239M +30.2M +14.5% Dec 31, 2014 10-K 2016-02-29
Q3 2014 238M +29.9M +14.4% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 238M +85.4M +55.9% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 209M +58M +38.4% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 209M +60.7M +41% Dec 31, 2013 10-K 2015-02-27
Q3 2013 209M +73M +53.8% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 153M +20.6M +15.6% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 151M +29.1M +23.9% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 148M +30.9M +26.4% Dec 31, 2012 10-K 2014-03-12
Q3 2012 136M +20.6M +17.9% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 132M +17.5M +15.2% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 122M Mar 31, 2012 10-Q 2012-05-09
Q4 2011 117M +5.99M +5.39% Dec 31, 2011 10-K 2013-03-12
Q3 2011 115M Sep 30, 2011 10-Q 2011-11-08
Q2 2011 115M Jun 30, 2011 10-Q 2011-08-09
Q4 2010 111M Dec 31, 2010 10-K 2012-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.